Article type
Year
Abstract
Background: Cochrane Russia was established in 2015 at the Kazan Federal University.
Objectives: To look back assessing outputs for the years (2019-2023) and to look forward planning for further capacity building in communicating evidence and advocating for research integrity.
Methods: We analyzed our Cochrane work and expressed the progress in numbers, led brainstorming sessions with the leadership of the host institution.
Results: Since 2021, Cochrane Russia works at its new home, the Russian Medical Academy for Continuing Professional Education (RMANPO), communicating Cochrane evidence (CE) through RMANPO news digests reaching out to 300,000+ of Russian healthcare providers. We deliver CE regularly through 5 Russian medical journals and include CE into articles of the Great Russian Encyclopaedia. By 2023, we reached 3,000+ Russian translations of Cochrane Plain Language Summaries (PLS) with 200+ volunteer translators, 160 podcasts and 350+ Blogshots, all Cochrane reports, 9 Cochrane Specials collections on COVID-19 with all updates, which resulted in Russian versions of Cochrane PLSs becoming the most accessed and read in the rise of pandemic in 2020, and De-implementation collection. Four Russian-language modules of Cochrane Evidence Essentials received the most active use among non-English versions in the fourth quarter of 2021. Cochrane MECIR standards appeared in Russian (2021) with annual update (2022) and will further follow English original. Russian version of the Evidence Commission report (2022) is available at McMaster Health Forum among seven global translations. We facilitate understanding of Cochrane evidence and advocate for its use at scientific and educational events, webinars, face-to-face workshops, masterclasses, round tables, and conference presentations (32 over the last 2 years). Since 2022, we are part of Cochrane Mentorship program with one mentee from Kazakhstan. The state provided subscription to the Cochrane Library for research/teaching health institutions; a Russian National subscription became a reality in 2022. Looking forward, we developed 8 educational modules on evidence synthesis, evidence-based medicine, clinical trials, and systematic reviews for future implementation.
Conclusions: Cochrane presence in Russia is well established. Cochrane values, mission, and spirit are highly respected, Cochrane reviews are regularly accessed and used.
Patient, public, and/or healthcare consumer involvement: We involve healthcare consumers in Russian translations.
Objectives: To look back assessing outputs for the years (2019-2023) and to look forward planning for further capacity building in communicating evidence and advocating for research integrity.
Methods: We analyzed our Cochrane work and expressed the progress in numbers, led brainstorming sessions with the leadership of the host institution.
Results: Since 2021, Cochrane Russia works at its new home, the Russian Medical Academy for Continuing Professional Education (RMANPO), communicating Cochrane evidence (CE) through RMANPO news digests reaching out to 300,000+ of Russian healthcare providers. We deliver CE regularly through 5 Russian medical journals and include CE into articles of the Great Russian Encyclopaedia. By 2023, we reached 3,000+ Russian translations of Cochrane Plain Language Summaries (PLS) with 200+ volunteer translators, 160 podcasts and 350+ Blogshots, all Cochrane reports, 9 Cochrane Specials collections on COVID-19 with all updates, which resulted in Russian versions of Cochrane PLSs becoming the most accessed and read in the rise of pandemic in 2020, and De-implementation collection. Four Russian-language modules of Cochrane Evidence Essentials received the most active use among non-English versions in the fourth quarter of 2021. Cochrane MECIR standards appeared in Russian (2021) with annual update (2022) and will further follow English original. Russian version of the Evidence Commission report (2022) is available at McMaster Health Forum among seven global translations. We facilitate understanding of Cochrane evidence and advocate for its use at scientific and educational events, webinars, face-to-face workshops, masterclasses, round tables, and conference presentations (32 over the last 2 years). Since 2022, we are part of Cochrane Mentorship program with one mentee from Kazakhstan. The state provided subscription to the Cochrane Library for research/teaching health institutions; a Russian National subscription became a reality in 2022. Looking forward, we developed 8 educational modules on evidence synthesis, evidence-based medicine, clinical trials, and systematic reviews for future implementation.
Conclusions: Cochrane presence in Russia is well established. Cochrane values, mission, and spirit are highly respected, Cochrane reviews are regularly accessed and used.
Patient, public, and/or healthcare consumer involvement: We involve healthcare consumers in Russian translations.